Literature DB >> 19190917

Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.

G P Schmidt1, A Baur-Melnyk, A Haug, S Utzschneider, C R Becker, R Tiling, M F Reiser, K A Hermann.   

Abstract

The purpose of this study was to assess the diagnostic accuracy of whole-body MRI (WB-MRI) at 1.5 T or 3 T compared with FDG-PET-CT in the follow-up of patients suffering from colorectal cancer. In a retrospective study, 24 patients with a history of colorectal cancer and suspected tumour recurrence underwent FDG-PET-CT and WB-MRI with the use of parallel imaging (PAT) for follow-up. High resolution coronal T1w-TSE and STIR sequences at four body levels, HASTE imaging of the lungs, contrast-enhanced T1w- and T2w-TSE sequences of the liver, brain, abdomen and pelvis were performed, using WB-MRI at either 1.5 T (n = 14) or 3 T (n = 10). Presence of local recurrent tumour, lymph node involvement and distant metastatic disease was confirmed using radiological follow-up within at least 5 months as a standard of reference. Seventy seven malignant foci in 17 of 24 patients (71%) were detected with both WB-MRI and PET-CT. Both investigations concordantly revealed two local recurrent tumours. PET-CT detected significantly more lymph node metastases (sensitivity 93%, n = 27/29) than WB-MRI (sensitivity 63%, n = 18/29). PET-CT and WB-MRI achieved a similar sensitivity for the detection of organ metastases with 80% and 78%, respectively (37/46 and 36/46). WB-MRI detected brain metastases in one patient. One false-positive local tumour recurrence was indicated by PET-CT. Overall diagnostic accuracy for PET-CT was 91% (sensitivity 86%, specificity 96%) and 83% for WB-MRI (sensitivity 72%, specificity 93%), respectively. Examination time for WB-MRI at 1.5 T and 3 T was 52 min and 43 min, respectively; examination time for PET-CT was 103 min. Initial results suggest that differences in accuracy for local and distant metastases detection using FDG-PET-CT and WB-MRI for integrated screening of tumour recurrence in colorectal cancer depend on the location of the malignant focus. Our results show that nodal disease is better detected using PET-CT, whereas organ disease is depicted equally well by both investigations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190917     DOI: 10.1007/s00330-008-1289-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  46 in total

1.  [Comparison of a T1-weighted inversion-recovery-, gradient-echo- and spin-echo sequence for imaging of the brain at 3.0 Tesla].

Authors:  C Stehling; T Niederstadt; S Krämer; H Kugel; W Schwindt; W Heindel; R Bachmann
Journal:  Rofo       Date:  2005-04

2.  High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study.

Authors:  Gerwin P Schmidt; Bernd Wintersperger; Anno Graser; Andrea Baur-Melnyk; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Invest Radiol       Date:  2007-06       Impact factor: 6.016

3.  (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer.

Authors:  Long-Bang Chen; Jin-Long Tong; Hai-Zhu Song; Hong Zhu; Yu-Cai Wang
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

Review 4.  The postoperative surveillance of patients with colon cancer and rectal cancer.

Authors:  Farshad Abir; Suraj Alva; Walter E Longo; Riccardo Audiso; Katherine S Virgo; Frank E Johnson
Journal:  Am J Surg       Date:  2006-07       Impact factor: 2.565

5.  Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?

Authors:  K U Juergens; M Weckesser; L Stegger; C Franzius; M Beetz; O Schober; W Heindel; D Wormanns
Journal:  Eur Radiol       Date:  2006-02-01       Impact factor: 5.315

6.  Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging.

Authors:  Sonja Kinner; Gerald Antoch; Andreas Bockisch; Patrick Veit-Haibach
Journal:  Abdom Imaging       Date:  2007 Sep-Oct

7.  Spectrum of MRI appearances of untreated metastases of the liver.

Authors:  Ioana-Maria Danet; Richard C Semelka; Polytimi Leonardou; Larissa Braga; Georgeta Vaidean; John T Woosley; Masayuki Kanematsu
Journal:  AJR Am J Roentgenol       Date:  2003-09       Impact factor: 3.959

8.  Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.

Authors:  Liviu V Titu; Anthony A Nicholson; John E Hartley; David J Breen; John R T Monson
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

9.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.

Authors:  Gerald Antoch; Florian M Vogt; Lutz S Freudenberg; Fridun Nazaradeh; Susanne C Goehde; Jörg Barkhausen; Gerlinde Dahmen; Andreas Bockisch; Jörg F Debatin; Stefan G Ruehm
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

10.  [VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].

Authors:  M Dobritz; T Radkow; M Nittka; W Bautz; F A Fellner
Journal:  Rofo       Date:  2002-06
View more
  24 in total

Review 1.  The uses and limitations of whole-body magnetic resonance imaging.

Authors:  Gerwin Schmidt; Dietmar Dinter; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Dtsch Arztebl Int       Date:  2010-06-04       Impact factor: 5.594

2.  Use of computed tomography in the management of colorectal cancer.

Authors:  Cher Heng Tan; Revathy Iyer
Journal:  World J Radiol       Date:  2010-05-28

Review 3.  Colorectal hepatic metastasis: Evolving therapies.

Authors:  Francisco Igor B Macedo; Tafadzwa Makarawo
Journal:  World J Hepatol       Date:  2014-07-27

Review 4.  Radiation risks associated with serial imaging in colorectal cancer patients: should we worry?

Authors:  Jeong Suk Oh; Jonathan B Koea
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 5.  Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma.

Authors:  Alberto Diaz de Leon; Ali Pirasteh; Daniel N Costa; Payal Kapur; Hans Hammers; James Brugarolas; Ivan Pedrosa
Journal:  Radiographics       Date:  2019-06-14       Impact factor: 5.333

6.  Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.

Authors:  Shu-Hang Ng; Sheng-Chieh Chan; Tzu-Chen Yen; Chun-Ta Liao; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Hung-Ming Wang; Chin-Yu Lin; Kai-Ping Chang; Yu-Chun Lin
Journal:  Eur Radiol       Date:  2010-09       Impact factor: 5.315

7.  Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology.

Authors:  Philipp Heusch; Felix Nensa; Benedikt Schaarschmidt; Rupika Sivanesapillai; Karsten Beiderwellen; Benedikt Gomez; Jens Köhler; Henning Reis; Verena Ruhlmann; Christian Buchbender
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-12       Impact factor: 9.236

8.  [Importance of whole body MRI for staging of colorectal cancer].

Authors:  G Schmidt
Journal:  Radiologe       Date:  2012-06       Impact factor: 0.635

9.  Detection of resectable recurrences in colorectal cancer patients with 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography.

Authors:  Nan-Jing Peng; Chin Hu; Tai-Ming King; Yu-Li Chiu; Jui-Ho Wang; Ren-Shyan Liu
Journal:  Cancer Biother Radiopharm       Date:  2013-05-28       Impact factor: 3.099

10.  Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series.

Authors:  C Brendle; N F Schwenzer; H Rempp; H Schmidt; C Pfannenberg; C la Fougère; K Nikolaou; C Schraml
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-31       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.